Ethics group publishes opinion on nanomedicine

Addressing safety concerns related to advances in the nanomedicine field is of vital importance, according to the newly published "Opinion on the Ethical Aspects of Nanomedicine" from the European Group on Ethics in Science and New Technologies.

The report, which was compiled following a request from European Commission President José Manuel Barroso, recognises the huge potential that nanomedicine offers in terms of developing new diagnostic, treatment and preventive methods.

On safety, the group proposes that measures be established to verify the safety of nanomedical products and devices, and calls on the relevant authorities to carry out a proper assessment of the risks and safety of nanomedicine.

"The Group considers it necessary for appropriate safety research to be carried out and information provided to the public before medical devices and medicinal products derived from nanotechnologies are marketed," states the report, adding that, "the Group considers it paramount that no nano-based products enter the market without risk assessment, thereby securing their safety with regard to users' health."

However, while knowledge gaps remain, researchers should not be afraid of admitting their existence. "Transparency is essential for public trust," the authors write. "This also holds for openness about uncertainties and knowledge gaps."

The group recommends that there should be an EU website on ethics and nanomedicine, where citizens can find information and pose questions to researchers. Furthermore, academic and public debates should be held on the issues raised by forthcoming developments in nanomedicine.

The report also places a strong emphasis on the importance of carrying out more research into the ethical, legal and social implications (ELSI) of nanomedicine. They recommend that up to 3% of the nanotechnology research budget be set aside for ELSI research. They also call on the European Commission to set up a dedicated European Network on Nanotechnology Ethics, financed through the Seventh Framework Programme (FP7). This network would bring together experts from a range of fields, promote deeper understanding of the ethical issues arising from nanotechnology and nanomedicine, promote education in these fields and work to ensure that ethics become embedded in research practices in nanomedicine and nanotechnology.

Looking beyond Europe, the group suggests that the Commission fund a study on the social effects on nanomedicine in developing countries. "Such research should also focus on macroeconomic trends, trade implications and possible international problems, and in particular examine the risk of creating a nano-divide which could widen the gap between the developed and developing countries," the authors write.

On the legal front, the group does not believe that structures set up specifically to deal with nanomedicine are needed right now. However, they suggest monitoring existing regulatory systems to ensure they do address all nanomedical products.

The European Commission spent over €1.36 billion on nanotechnology research under the Sixth Framework Programme. The nanotechnology budget under FP7 is €3.5 billion, and around €100 million per year is expected to be allocated to projects in the field of nanomedicine.

For further information, please visit:
http://ec.europa.eu/european_group_ethics/index_en.htm

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...